A costly factor in enforcement action undermines the Rule of Law: UK Supreme Court Rules on CMA v Pfizer/Flynn costs appeal
On 25 May 2022, the UK Supreme Court gave its judgment on CMA v Flynn Pharma Ltd and Pfizer Inc in relation to a CAT decision on costs for public regulators. This is a vitally important case in relation to public interest enforcement of the law. It reaffirms that the judge must decide who pays…